David is a geneticist and cell biologist, with a keen interest in understanding the form and function of subcellular structures and their implications in diseases. As a Senior Scientist at Interline, David will use functional genomics to identify and interrogate key disease modulators. David did his Ph.D. work in David Ginty’s lab at Johns Hopkins and Harvard Medical School, where he discovered a novel signaling pathway that governs the communications between adipose tissues and the sympathetic nervous system, and its implications in diabetes and obesity. Subsequently, David performed postdoctoral research in Michael Rape’s lab at UC Berkeley where he developed cell-based CRISPR screening platforms to discover key, novel degradation enzymes for neurodegenerative diseases.
Outside of the lab, David is inspired by literature, design and architecture.